News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
630,646 Results
Type
Article (60669)
Company Profile (78)
Press Release (569899)
Section
Business (173319)
Career Advice (2710)
Deals (32359)
Drug Delivery (85)
Drug Development (76624)
Employer Resources (148)
FDA (14837)
Job Trends (13833)
News (304348)
Policy (29198)
Tag
Academia (2871)
Alliances (42757)
Alzheimer's disease (1160)
Approvals (14766)
Artificial intelligence (122)
Bankruptcy (280)
Best Places to Work (10702)
Breast cancer (106)
Cancer (923)
Career advice (2291)
Cell therapy (213)
Clinical research (60519)
Collaboration (321)
Compensation (98)
COVID-19 (2509)
C-suite (91)
Cystic fibrosis (77)
Data (882)
Diabetes (125)
Diagnostics (5893)
Drug pricing (78)
Earnings (58031)
Employer resources (131)
Events (91417)
Executive appointments (262)
FDA (15288)
Funding (286)
Gene therapy (151)
GLP-1 (539)
Government (4547)
Healthcare (18111)
Infectious disease (2578)
Inflammatory bowel disease (101)
Interviews (521)
IPO (14570)
Job creations (3409)
Job search strategy (1936)
Layoffs (438)
Legal (6409)
Lung cancer (147)
Manufacturing (144)
Medical device (12445)
Medtech (12450)
Mergers & acquisitions (17868)
Metabolic disorders (336)
Neuroscience (1390)
NextGen Class of 2024 (6354)
Non-profit (4306)
Northern California (1128)
Obesity (192)
Opinion (201)
Patents (94)
People (58358)
Phase I (18962)
Phase II (26703)
Phase III (19535)
Pipeline (243)
Postmarket research (2466)
Preclinical (8096)
Radiopharmaceuticals (238)
Rare diseases (187)
Real estate (5963)
Regulatory (19424)
Research institute (2382)
Resumes & cover letters (404)
Southern California (1019)
Startups (3326)
United States (10806)
Vaccines (522)
Weight loss (142)
Date
Today (208)
Last 7 days (831)
Last 30 days (2982)
Last 365 days (32440)
2024 (28131)
2023 (36364)
2022 (46631)
2021 (51604)
2020 (50786)
2019 (44893)
2018 (34135)
2017 (30725)
2016 (30067)
2015 (35446)
2014 (28388)
2013 (24955)
2012 (26217)
2011 (26458)
2010 (24932)
Location
Africa (865)
Arizona (132)
Asia (37263)
Australia (6701)
California (2501)
Canada (1085)
China (195)
Colorado (120)
Connecticut (115)
Europe (86542)
Florida (375)
Georgia (99)
Illinois (321)
Indiana (161)
Kansas (87)
Maryland (491)
Massachusetts (1942)
Michigan (144)
Minnesota (211)
New Jersey (791)
New York (771)
North Carolina (678)
Northern California (1128)
Ohio (121)
Pennsylvania (678)
South America (1171)
Southern California (1019)
Texas (366)
Utah (80)
Washington State (291)
630,646 Results for "university of ottawa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department of Neuroscience (Ottawa, Canada), will present data from a study investigating the mechanisms of BETR-001 (2-bromo-LSD) at the upcoming FENS conference on June 25-29 in Vienna, Austria.
June 26, 2024
·
4 min read
Convergent Imaging Solutions announces public tender win for nuclear medicine workstations in home base of Ottawa, Ontario
Convergent Imaging Solutions, a leader in workflow optimized medical image fusion and nuclear medicine software, announced that it has won the public tender for nuclear medicine processing software at Hôpital Montfort, in Ottawa, Canada.
July 13, 2023
·
2 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
Rosalind Franklin University Helix 51 Biomedical Incubator Marks Fifth Anniversary, Rapid Expansion
NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...
May 15, 2024
·
2 min read
Press Releases
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
October 8, 2024
·
6 min read
Intensity Therapeutics, The Ottawa Hospital and Ontario Institute for Cancer Research Report INT230-6 Demonstrates Tumor Necrosis and Immune Activation in Early Stage Breast Cancers
Intensity Therapeutics, Inc. along with The Ottawa Hospital and Ontario Institute of Cancer Research, will present updated data from the INVINCIBLE study, a randomized, phase 2 presurgical window of opportunity trial for Intensity’s intratumoral INT230-6 comprising SHAO, vinblastine and cisplatin, that is evaluating clinical and biological effects in patients with early-stage operable breast cancer.
November 10, 2022
·
10 min read
BioMidwest
University Cancer & Blood Center and University Health Alliance open High-Risk GI Clinic to address community needs
University Cancer & Blood Center, a leading oncology and hematology practice for Northeast Georgia, and University Health Alliance, a multi-disciplinary practice focusing on prevention and coordinated care, announce the opening of their High-Risk GI Clinic.
April 10, 2024
·
3 min read
1 of 63,065
Next